Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peer Group | 2 | 2024 | 177 | 1.550 |
Why?
|
| Students, Medical | 2 | 2024 | 158 | 1.470 |
Why?
|
| Burnout, Professional | 2 | 2024 | 31 | 1.070 |
Why?
|
| Metamorphosis, Biological | 2 | 2009 | 15 | 0.490 |
Why?
|
| Triiodothyronine | 2 | 2009 | 36 | 0.480 |
Why?
|
| Blood Platelets | 3 | 2020 | 81 | 0.430 |
Why?
|
| Neuromuscular Junction | 5 | 2006 | 35 | 0.400 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2024 | 95 | 0.400 |
Why?
|
| Rana catesbeiana | 4 | 2009 | 29 | 0.390 |
Why?
|
| Retina | 3 | 2025 | 289 | 0.350 |
Why?
|
| Receptors, Nicotinic | 7 | 2007 | 114 | 0.330 |
Why?
|
| Locomotion | 2 | 2014 | 105 | 0.300 |
Why?
|
| Swimming | 1 | 2009 | 41 | 0.290 |
Why?
|
| Thyrotropin | 1 | 2008 | 24 | 0.270 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2008 | 43 | 0.270 |
Why?
|
| Menopause | 1 | 2008 | 64 | 0.270 |
Why?
|
| Alzheimer Disease | 3 | 2020 | 1001 | 0.260 |
Why?
|
| Potassium Channels | 3 | 2002 | 80 | 0.250 |
Why?
|
| Spermine Synthase | 1 | 2025 | 3 | 0.240 |
Why?
|
| Tryptophan | 5 | 2004 | 66 | 0.240 |
Why?
|
| Neuroglia | 3 | 2025 | 133 | 0.240 |
Why?
|
| Tail | 2 | 2003 | 5 | 0.220 |
Why?
|
| Receptors, Cholinergic | 4 | 2004 | 28 | 0.210 |
Why?
|
| Puerto Rico | 2 | 2024 | 1413 | 0.200 |
Why?
|
| Young Adult | 2 | 2024 | 5080 | 0.200 |
Why?
|
| Triiodothyronine, Reverse | 1 | 2003 | 3 | 0.200 |
Why?
|
| Torpedo | 7 | 2004 | 41 | 0.200 |
Why?
|
| Choroid | 1 | 2022 | 11 | 0.180 |
Why?
|
| Vertebrates | 1 | 2022 | 34 | 0.180 |
Why?
|
| Amino Acid Substitution | 6 | 2006 | 135 | 0.180 |
Why?
|
| Patch-Clamp Techniques | 9 | 2014 | 228 | 0.180 |
Why?
|
| Animals | 24 | 2025 | 16992 | 0.180 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2019 | 95 | 0.180 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 1081 | 0.160 |
Why?
|
| Amyloidosis | 1 | 2020 | 37 | 0.160 |
Why?
|
| Aging | 1 | 2025 | 783 | 0.160 |
Why?
|
| Adult | 3 | 2024 | 13872 | 0.160 |
Why?
|
| Acetylcholine | 5 | 2006 | 77 | 0.140 |
Why?
|
| Parkinson Disease | 1 | 2020 | 210 | 0.140 |
Why?
|
| Glaucoma | 1 | 2019 | 100 | 0.130 |
Why?
|
| Membrane Potentials | 6 | 2003 | 222 | 0.130 |
Why?
|
| Male | 7 | 2024 | 23409 | 0.130 |
Why?
|
| Oocytes | 8 | 2007 | 149 | 0.130 |
Why?
|
| Larva | 3 | 2003 | 133 | 0.130 |
Why?
|
| Hemeproteins | 1 | 2016 | 15 | 0.120 |
Why?
|
| Chemical Phenomena | 1 | 2016 | 56 | 0.120 |
Why?
|
| Magnetics | 1 | 2016 | 43 | 0.120 |
Why?
|
| Muscles | 2 | 1988 | 82 | 0.120 |
Why?
|
| Humans | 10 | 2024 | 43102 | 0.120 |
Why?
|
| Bufo marinus | 3 | 1991 | 6 | 0.120 |
Why?
|
| Protein Subunits | 3 | 2004 | 93 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3156 | 0.120 |
Why?
|
| Quinine | 1 | 2014 | 12 | 0.110 |
Why?
|
| Brain | 2 | 2020 | 1472 | 0.110 |
Why?
|
| Ion Channels | 3 | 2006 | 74 | 0.110 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2014 | 13 | 0.110 |
Why?
|
| Membrane Lipids | 2 | 2007 | 30 | 0.110 |
Why?
|
| Myasthenic Syndromes, Congenital | 2 | 2006 | 4 | 0.110 |
Why?
|
| Female | 3 | 2024 | 24698 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 81 | 0.110 |
Why?
|
| Ventral Tegmental Area | 1 | 2014 | 49 | 0.110 |
Why?
|
| Ion Channel Gating | 3 | 2004 | 82 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2014 | 373 | 0.090 |
Why?
|
| Xenopus laevis | 7 | 2007 | 73 | 0.090 |
Why?
|
| Cocaine | 1 | 2014 | 251 | 0.090 |
Why?
|
| Mutation | 3 | 2006 | 1177 | 0.080 |
Why?
|
| Synaptic Transmission | 2 | 2006 | 149 | 0.080 |
Why?
|
| Synapses | 1 | 1991 | 185 | 0.080 |
Why?
|
| Cheek | 1 | 2009 | 13 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2004 | 186 | 0.070 |
Why?
|
| Electrophysiological Phenomena | 1 | 2009 | 20 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 6 | 2007 | 423 | 0.070 |
Why?
|
| Kinetics | 4 | 2006 | 695 | 0.070 |
Why?
|
| Neurons | 2 | 2025 | 1263 | 0.070 |
Why?
|
| Muscle Proteins | 1 | 2007 | 51 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2008 | 490 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 296 | 0.060 |
Why?
|
| Cell Membrane | 3 | 2004 | 403 | 0.060 |
Why?
|
| Spermine | 1 | 2025 | 67 | 0.060 |
Why?
|
| Potassium Compounds | 1 | 1984 | 4 | 0.050 |
Why?
|
| Fluorides | 1 | 1984 | 19 | 0.050 |
Why?
|
| Bungarotoxins | 4 | 2007 | 21 | 0.050 |
Why?
|
| Sodium | 1 | 1984 | 102 | 0.050 |
Why?
|
| Xenopus | 4 | 2004 | 48 | 0.050 |
Why?
|
| Niflumic Acid | 1 | 2003 | 1 | 0.050 |
Why?
|
| Chloride Channels | 1 | 2003 | 4 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2003 | 36 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2003 | 69 | 0.050 |
Why?
|
| Ranidae | 1 | 2002 | 12 | 0.050 |
Why?
|
| Muscle Weakness | 1 | 2002 | 7 | 0.050 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2002 | 64 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2022 | 210 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2004 | 536 | 0.040 |
Why?
|
| Nicotine | 1 | 2004 | 302 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 2853 | 0.040 |
Why?
|
| Rats | 2 | 2025 | 3735 | 0.040 |
Why?
|
| Calcium | 1 | 2003 | 491 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2001 | 148 | 0.040 |
Why?
|
| Cholesterol | 1 | 2001 | 232 | 0.040 |
Why?
|
| Amino Acid Sequence | 4 | 2004 | 1180 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2004 | 1542 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2020 | 117 | 0.040 |
Why?
|
| Neural Conduction | 1 | 1999 | 17 | 0.040 |
Why?
|
| Aged | 2 | 2008 | 8214 | 0.030 |
Why?
|
| Gene Expression | 3 | 2007 | 701 | 0.030 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2014 | 4 | 0.030 |
Why?
|
| Prazosin | 1 | 2014 | 9 | 0.030 |
Why?
|
| Adrenergic Agents | 1 | 2014 | 8 | 0.030 |
Why?
|
| Temperature | 1 | 2016 | 313 | 0.030 |
Why?
|
| Benzophenanthridines | 1 | 2014 | 14 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2014 | 12 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1596 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 36 | 0.030 |
Why?
|
| Phenylephrine | 1 | 2014 | 34 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2014 | 35 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2014 | 59 | 0.030 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 19 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2014 | 186 | 0.030 |
Why?
|
| Presynaptic Terminals | 1 | 2014 | 54 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 195 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 2004 | 182 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2014 | 124 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2004 | 267 | 0.020 |
Why?
|
| Models, Molecular | 3 | 2001 | 876 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 159 | 0.020 |
Why?
|
| Indoles | 1 | 2014 | 187 | 0.020 |
Why?
|
| Dopamine | 1 | 2014 | 275 | 0.020 |
Why?
|
| Electric Conductivity | 2 | 2000 | 55 | 0.020 |
Why?
|
| Middle Aged | 1 | 2008 | 12222 | 0.020 |
Why?
|
| Binding Sites | 2 | 2004 | 671 | 0.020 |
Why?
|
| Protein Conformation | 2 | 2003 | 416 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1991 | 159 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1766 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 1124 | 0.020 |
Why?
|
| Mice | 2 | 2014 | 6644 | 0.020 |
Why?
|
| Pedigree | 1 | 2006 | 94 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2006 | 80 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2006 | 57 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2006 | 107 | 0.010 |
Why?
|
| Cesium | 1 | 1984 | 8 | 0.010 |
Why?
|
| Microinjections | 1 | 2004 | 50 | 0.010 |
Why?
|
| Permeability | 1 | 1984 | 67 | 0.010 |
Why?
|
| Potassium | 1 | 1984 | 109 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2003 | 65 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2003 | 91 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 316 | 0.010 |
Why?
|
| Tolbutamide | 1 | 2002 | 4 | 0.010 |
Why?
|
| Rana pipiens | 1 | 2002 | 63 | 0.010 |
Why?
|
| Motor Endplate | 1 | 2002 | 3 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2002 | 55 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 2002 | 61 | 0.010 |
Why?
|
| Molecular Probes | 1 | 2001 | 23 | 0.010 |
Why?
|
| Electromyography | 1 | 2002 | 69 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2002 | 82 | 0.010 |
Why?
|
| Point Mutation | 1 | 2002 | 98 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2002 | 206 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 1082 | 0.010 |
Why?
|
| Allosteric Site | 1 | 2000 | 12 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 300 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 184 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 934 | 0.010 |
Why?
|
| Time Factors | 1 | 1984 | 1857 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 1070 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2000 | 506 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2002 | 1621 | 0.010 |
Why?
|
| Child | 1 | 2002 | 3443 | 0.010 |
Why?
|
| Adolescent | 1 | 2002 | 6081 | 0.010 |
Why?
|